Icon

NOLVADEX (nda017970)- (EQ 10MG BASE,EQ 20MG BASE)

TAMOXIFEN CITRATE ASTRAZENECA
EQ 10MG BASE,EQ 20MG BASE
Yes No
2003-Feb-20 Expired
None None
None No
OLVADEX is effective in the treatment of metastatic breast cancer in women and men. NOLVADEX is indicated for the treatment of node-positive breast cancer in postmenopausal women following total mastectomy or segmental mastectomy, axillary dissection, and breast irradiation. NOLVADEX is indicated for the treatment of axillary node-negative breast cancer in women following total mastectomy or segmental mastectomy, axillary dissection, and breast irradiation. NOLVADEX reduces the occurrence of contralateral breast cancer in patients receiving adjuvant NOLVADEX therapy for breast cancer.
6 0 5
Total Other Developers None
Drugs with Suitability No
EQ 10MG BASE ** ** - - 4
EQ 20MG BASE ** ** - - 4
NDA Sales Available Total Generic Sales Available
No 5
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ******* **** ** *** ******* ************ **, ***. *********** **** ****** *****, *****, ******* (**) *****, ****** ****** (***) ***
****** ** ****** **** ** ******** **********, ***. *********** **** **** *******, **********, ***** ******** (**) *****, ****** ****** (***) ***
****** ***** ****** ***** ************ ******* *********** **** **. *-*/*&* *******, (******* ******** ****) ******, ******* ***** *.*. **. **, ***-******, ****-*********, *********, ******* ******, ***** (***) ***
****** ***** ****** ***** ****** ************ ******* *********** ****-*, **. **. ***, *** & ***, ******* *******, ********* ******, *******-**********, ********* ******, ***** (***) ***
****** ** ****** **** ** **** ************** ********** ***. *********** ** *** ******* ******, ********** ****, **** ****, *******, ****** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.